Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy)
Paolo A. Ascierto, Sanjiv S. Agarwala, Allison Betof Warner, Marc S. Ernstoff, Bernard A. Fox, Thomas F. Gajewski, Jérôme Galon, Claus Garbe, Brian R. Gastman, Jeffrey E. Gershenwald, Pawel Kalinski, Michelle Krogsgaard, Rom S. Leidner, Roger S. Lo, Alexander M. Menzies, Olivier Michielin, Poulikos I. Poulikakos, Jeffrey S. Weber, Corrado Caracò, Iman Osman, Igor Puzanov, Magdalena Thurinv
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
Paolo A. Ascierto, Antonio Avallone, Carlo Bifulco, Sergio Bracarda, Joshua D. Brody, Leisha A. Emens, Robert L. Ferris, Silvia C. Formenti, Omid Hamid, Douglas B. Johnson, Tomas Kirchhoff, Christopher A. Klebanoff, Gregory B. Lesinski, Anne Monette, Bart Neyns, Kunle Odunsi, Chrystal M. Paulos, Daniel J. Powell Jr., Katayoun Rezvani, Brahm H. Segal, Nathan Singh, Ryan J. Sullivan, Bernard A. Fox , Igor Puzanovv
The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022)
Paolo A. Ascierto, Christian Blank, Alexander M. Eggermont, Claus Garbe, Jeffrey E. Gershenwald, Omid Hamid, Axel Hauschild, Jason J. Luke, Janice M. Mehnert, Jeffrey A. Sosman, Hussein A. Tawbi, Mario Mandalà, Alessandro Testori, Corrado Caracò, Iman Osman, Igor Puzanov
The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022)
Paolo A. Ascierto, Renier Brentjens, Samir N. Khleif, Kunle Odunsi, Katayoun Rezvani, Marco Ruella, Ryan J. Sullivan, Bernard A. Fox & Igor Puzanov
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd – 4th, 2021, Italy)
Paolo A. Ascierto , Sanjiv S. Agarwala, Christian Blank, Corrado Caracò, Richard D. Carvajal, Marc S. Ernstoff, Soldano Ferrone, Bernard A. Fox, Thomas F. Gajewski, Claus Garbe, Jean‑Jacques Grob, Omid Hamid, Michelle Krogsgaard, Roger S. Lo, Amanda W. Lund, Gabriele Madonna, Olivier Michielin, Bart Neyns, Iman Osman, Solange Peters, Poulikos I. Poulikakos, Sergio A. Quezada, Bradley Reinfeld, Laurence Zitvogel, Igor Puzanov, Magdalena Thurin.
Ascierto et al.
Journal of Translational Medicine (2022) 20:391
Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021
Elizabeth M. Burton , Rodabe N. Amaria, Tina Cascone, Myriam Chalabi, Neil D. Gross,
Elizabeth A. Mittendorf, Richard A. Scolyer, Padmanee Sharma and Paolo A. Ascierto
Burton et al. Journal of Translational Medicine (2022) 20:271
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
Paolo A. Ascierto , Antonio Avallone, Nina Bhardwaj, Carlo Bifulco, Sergio Bracarda, Joshua D. Brody,
Luigi Buonaguro, Sandra Demaria, Leisha A. Emens, Robert L. Ferris, Jérôme Galon, Samir N. Khleif,
Christopher A. Klebanoff, Tamara Laskowski, Ignacio Melero, Chrystal M. Paulos, Sandro Pignata,
Marco Ruella, Inge Marie Svane, Janis M. Taube, Bernard A. Fox, Patrick Hwu, Igor Puzanov.
Ascierto et al.
Journal of Translational Medicine (2022) 20:257
The “Great Debate” at Melanoma Bridge 2021: December, 2nd-4th, 2021
Paolo A. Ascierto, Allison Betof Warner, Christian Blank, Corrado Caracò, Sandra Demaria,
Jeffrey E. Gershenwald, Nikhil I. Khushalani, Georgina V. Long, Jason J. Luke, Janice M. Mehnert,
Caroline Robert, Piotr Rutkowski, Hussein A. Tawbi, Iman Osman, Igor Puzanov
Ascierto et al. J Transl Med (2022) 20:200
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
Paolo A. Ascierto, Lisa H. Butterfield, Olivera J. Finn, Andrew Futreal, Omid Hamid, Theresa LaVallee, Michael A. Postow, Igor Puzanov, Jeffrey Sosman, Bernard A. Fox, Patrick Hwu
Ascierto et al. Journal of Translational Medicine (2022) 20:179
Immunotherapy Bridge 2021 and Melanoma Bridge 2021: meeting abstracts, December 1st 4nd 2021
Paolo A. Ascierto, Carlo Bifulco, Sandra Demaria, Reinhard Dummer, Bernard A. Fox, Patrick Hwu, Francesco Marincola, Giuseppe Masucci, Iman Osman, Igor Puzanov.
J Transl Med 2021, 19(Suppl 1):110
PERSPECTIVES IN MELANOMA: MEETING REPORT FROM THE “MELANOMA BRIDGE”, NAPOLI, DECEMBER 3rd-5th 2020
Paolo A. Ascierto , Christian Blank, Reinhard Dummer, Marc S. Ernstoff, Soldano Ferrone, Bernard A. Fox, Thomas F. Gajewski, Claus Garbe, Patrick Hwu, Pawel Kalinski, Michelle Krogsgaard, Roger S. Lo, Jason J. Luke, Bart Neyns, Michael A. Postow, Sergio A. Quezada, Michele W. L. Teng, Giorgio Trinchieri, Alessandro Testori, Corrado Caracò, Iman Osman, Igor Puzanov and Magdalena Thurin
Ascierto et al. J Transl Med (2021) 19:278
PERSPECTIVES IN IMMUNOTHERAPY: MEETING REPORT FROM THE “IMMUNOTHERAPY BRIDGE”, NAPOLI, DECEMBER 2nd-3rd 2020
Paolo A. Ascierto , Carlo Bifulco, Fortunato Ciardiello, Sandra Demaria, Leisha A. Emens, Robert Ferris, Silvia C. Formenti, Jerome Galon, Samir N. Khleif, Tomas Kirchhoff, Jennifer McQuade, Kunle Odunsi, Akash Patnaik, Chrystal M. Paulos, Janis M. Taube, John Timmerman, Bernard A. Fox, Patrick Hwu and Igor Puzanov.
Ascierto et al. J Transl Med (2021) 19:238
The “Great Debate” at Melanoma Bridge 2020: December, 5th, 2020
Paolo A. Ascierto , Michael B. Atkins, Alexander M. Eggermont, Jeffrey E. Gershenwald, Jean‑Jacques Grob, Omid Hamid, Vernon K. Sondak, Jeffrey A. Sosman, Hussein A. Tawbi, Jeffrey S. Weber, Corrado Caracò, Iman Osman and Igor Puzanov
Ascierto et al. J Transl Med (2021) 19:142
The “Great Debate” at Immunotherapy Bridge 2020, December 3rd, 2020
Paolo A. Ascierto, Joshua Brody, Lisa H. Butterfield, Olivera J. Finn, John Goldberg, Francesco Perrone, Ryan J. Sullivan, Bernard A. Fox, Patrick Hwu & Igor Puzanov
Ascierto et al. J Transl Med (2021) 19:144
Critical concepts and management recommendations for cutaneous T‐cell lymphoma: A consensus‐based position paper from the Italian Group of Cutaneous Lymphoma
Pier Luigi Zinzani Pietro Quaglino Silvia Alberti Violetti Maria Cantonetti Gaia Goteri Francesco Onida Marco Paulli Serena Rupoli Giovanni Barosi Nicola Pimpinelli
Immunotherapy Bridge 2020 and Melanoma Bridge 2020: meeting abstracts, December 1st 2nd 2020
Paolo A. Ascierto, Carlo Bifulco, Sandra Demaria, Reinhard Dummer, Patrick Hwu, Francesco Marincola, Giuseppe Masucci, Iman Osman, Igor Puzanov.
J Transl Med 2021, 19(Suppl 1):110
THE GREAT DEBATE AT “IMMUNOTHERAPY BRIDGE”, Naples, December 5th 2019
Paolo A Ascierto , Carlo Bifulco, Jerome Galon, Claus Garbe, Samir N Khleif, Jennifer McQuade, Kunle Odunsi, Hideho Okada , Chrystal M Paulos, Sergio A Quezada, Hussein A Tawbi , John Timmerman, Giorgio Trinchieri, Lisa H Butterfield, Igor Puzanov
Ascierto PA, et al. J Immunother Cancer 2020;8:e000921
PERSPECTIVES IN MELANOMA: MEETING REPORT FROM THE “MELANOMA BRIDGE”, Naples, December 5th – December 7th 2019
Paolo A. Ascierto, Igor Puzanov, Sanjiv S. Agarwala, Christian Blank, Richard D. Carvajal, Sandra Demaria, Reinhard Dummer, Marc Ernstoff, Soldano Ferrone, Bernard A. Fox, Thomas F. Gajewski, Claus Garbe, Patrick Hwu, Roger S. Lo, Georgina V. Long, Jason J. Luke,
Iman Osman, Michael A. Postow, Ryan J. Sullivan, Janis M. Taube, Giorgio Trinchieri, Hassane M. Zarour, Corrado Caracò and Magdalena Thurin
Ascierto et al. J Transl Med (2020) 18:346
THE GREAT DEBATE AT “MELANOMA BRIDGE 2019”, Naples, December 7th, 2019
Paolo A. Ascierto, Sanjiv S. Agarwala, Alexander Eggermont, Jeffrey E. Gershenwald, Jean‑Jacques Grob, Omid Hamid6, Olivier Michielin, Michael Postow, Igor Puzanov, Hassane M. Zarour, Corrado Caracò and Alessandro Testori
Ascierto et al. J Transl Med (2020) 18:171
UPDATES AND NEW PERSPECTIVES IN NONMELANOMA SKIN CANCER THERAPY: HIGHLIGHTS FROM ‘IMMUNOTHERAPY BRIDGE’
Paolo Antonio Ascierto & Claus Garbe
FutureMedicine (2019)
IMMUNOTHERAPY BRIDGE 2019 AND MELANOMA BRIDGE 2019: MEETING ABSTRACTS
J Transl Med 2020, 18(Suppl 1):50
THE GREAT DEBATE AT “IMMUNOTHERAPY BRIDGE 2018”, Naples, November 29th, 2018
Ascierto P.A., Butterfield L.H., Demaria S., Ferris R.L., Freeman G.J., Lo R.S., Mantovani A., Nathan P., Hamid O., Politi K. and Puzanov I.
Ascierto et al. Journal for ImmunoTherapy of Cancer (2019) 7:221
PERSPECTIVES IN MELANOMA: MEETING REPORT FROM THE “MELANOMA BRIDGE”, Napoli, November 29th-December 1st 2018
Ascierto P.A., Agarwala S.S., Botti G., Budillon A., Davies A., Dummer R., Ernstof M., Eggermont A., Ferrone S., Formenti S., Gajewski T.F., Garbe C., Hamid O., Lo R.S, Luke J.J., Michielin O., Palmieri G., Zitvogel L., Marincola F.M., Masucci G., Caracò C., Thurin M. and Puzanov I.
Ascierto et al. J Transl Med (2019) 17:234
THE GREAT DEBATE AT “MELANOMA BRIDGE”, Napoli, December 1st, 2018
Ascierto P.A., Bruzzi P., Eggermont A., Hamid O., Tawbi H.A., van Akkooi A., Testori A., Caracò C., Puzanov I. and Perrone F.
Ascierto et al. J Transl Med (2019) 17:148
IMMUNOTHERAPY BRIDGE 2018 AND MELANOMA BRIDGE 2018: MEETING ABSTRACTS
J Transl Med 2019, 17(Suppl 1):16
PERSPECTIVES IN IMMUNOTHERAPY: MEETING REPORT FROM THE IMMUNOTHERAPY BRIDGE, Napoli, November 29th-30th 2017
Ascierto P.A., Brugarolas J., Buonaguro L., Butterfield L.H., Carbone D., Daniele B., Ferris R., Fox B.A., Galon J., Gridelli C., Kaufman H.L., Klebanoff C.A., Melero I., Nathan P., Paulos C.M., Ruella M., Sullivan R., Zarour H. and Puzanov I.
Ascierto et al. Journal for ImmunoTherapy of Cancer (2018) 6:69
PERSPECTIVES IN MELANOMA: MEETING REPORT FROM THE “MELANOMA BRIDGE”, Napoli, November 30thndDecember 2nd 2017
Ascierto P.A., Puzanov I., Agarwala S.S., Bifulco C. , Botti G., Caracò C., Ciliberto G. , Davies M.A., D/wp-content/uploads/Great-Debate-jtm.pdfummer R., Ferrone S., Gajewski T.F., Garbe C., Luke J.J., Marincola F.M., Masucci G., Mehnert J.M., Mozzillo N., Palmieri G., Postow M.A., Schoenberger S.P., Wang E., Thurin M.
Journal: Ascierto et al. J Transl Med (2018) 16:207
THE GREAT DEBATE AT “MELANOMA BRIDGE”, Napoli, December 2nd, 2017
Ascierto P.A., Caracò C., Gershenwald J.E., Hamid O., Ross M., Sullivan R.J., Puzanov I.
Journal: Ascierto et al. J Transl Med (2018) 16:101
IMMUNOTHERAPY AND MELANOMA BRIDGE 2017 MEETING ABSTRACTS
J Transl Med 2018, 16(Suppl 1):4
“FUTURE PERSPECTIVES IN MELANOMA RESEARCH “MELANOMA BRIDGE”, NAPOLI, NOVEMBER 30TH-3RD DECEMBER 2016
Ascierto P.A., Agarwala S.S., Ciliberto G., Demaria S., Dummer R., Duong C.P.M., Ferrone S., Formenti S.C., Garbe C., Halaban R., Khleif S., Luke J.J., Mir L.M., Overwijk W.W., Postow P., Puzanov I., Sondel P., Taube J.M., Straten P.T., Stroncek D.F., Wargo J.A., Zarour H., Thurin M.
Journal: Ascierto et al. J Transl Med (2017) 15:236
LE MALATTIE RARE IN ITALIA FOCUS SU EMOFILIA B
Source: www.pharmastar.it
PERSPECTIVES IN IMMUNOTHERAPY: MEETING REPORT FROM THE “IMMUNOTHERAPY BRIDGE”, NAPOLI, NOVEMBER 30TH 2016
Ascierto P.A., Daniele B., Hammers H., Hirsh V., Kim J., Licitra L., Nanda R., Pignata S.
Journal: Ascierto et al. J Transl Med (2017) 15:205
WORLD-WIDE IMMUNOSCORE TASK FORCE: MEETING REPORT FROM THE “MELANOMA BRIDGE”, NAPOLI, NOVEMBER 30TH–DECEMBER 3RD, 2016
Galon J., Lugli A., Bifulco C., Pages F., Masucci G., Marincola F.M., Ascierto P.A.
Journal: Galon et al. J Transl Med (2017) 15:212
PRIMARY BILIARY CHOLANGITIS: ADVANCES IN MANAGEMENT AND TREATMENT OF THE DISEASE
Invernizzi P, Floreani A, Carbone M, Marzioni M, Craxi A, Muratori L, Vespasiani Gentilucci U, Gardini I, Gasbarrini A, Kruger P, Mennini FS, Ronco V, Lanati EP, Canonico PL, Alvaro D
Journal: Dig Liver Dis. 2017 May;S1590-8658(17)30857-5
IMMUNOTHERAPY AND MELANOMA BRIDGE 2016 MEETING ABSTRACTS
J Transl Med 2017, 15(Suppl 1):8
SIXTH WORKSHOP ON ECONOMICS AND DRUGS IN HEPATOLOGY (WEF E 2016)
Greco A.V., Gasbarrini A. Guest Editors: Gasbarrini A., Cicchetti A.
Eur Rev Med Pharmacol Sci 2016; 20 (1 Suppl)
IMMUNOTHERAPY AND MELANOMA BRIDGE 2015 MEETING ABSTRACTS
J Transl Med 2016, 14(Suppl 1):S65
IMMUNOSCORE AND IMMUNOPROFILING IN CANCER: AN UPDATE FROM THE MELANOMA AND IMMUNOTHERAPY BRIDGE 2015
Galon J., Fox B.A., Bifulco C.B., Masucci G., Rau T., Botti G., Marincola F.M., Ciliberto G., Pages F., Ascierto P.A. and Capone M.
Galon et al. J Transl Med (2016) 14:273
FUTURE PERSPECTIVES IN MELANOMA RESEARCH. MEETING REPORT FROM THE “MELANOMA BRIDGE. NAPOLI, DECEMBER 1st-4th 2015”
Ascierto P.A., Agarwala S., Botti G., Cesano A., Ciliberto G., Davies M.A., Demaria S., Dummer R., . Eggermont A.M., Ferrone S., Xin Fu Y., Gajewski T.F., Garbe C., Huber V., Khleif S., Krauthammer M., Lo R.S., Masucci G., Postow M., Puzanov I., Silk A., Spranger S., Stroncek D.F., Tarhini A., Taube J., Testori A., Wang E., Wargo J.A., Yee C., Zarour H., Zitvogel L., Fox B.A., Mozzillo N., Marincola F.M. and Thurin M.
Ascierto et al. J Transl Med (2016) 14:313
PERSPECTIVES IN IMMUNOTHERAPY: MEETING REPORT FROM THE “IMMUNOTHERAPY BRIDGE” , NAPOLI, DECEMBER 5th 2015
Ascierto P.A., Ascierto M.L., Formenti S., Gnjatic R., Hammers H., Hirsh V., Kiessling V., Melero I., Nanda R., Pawelec G., Pignata S., Romero P., Speiser D.E., Fox B.A. and Marincola F.M.
Ascierto et al. Journal for ImmunoTherapy of Cancer (2016) 4:62
FUTURE PERSPECTIVES IN MELANOMA RESEARCH. MEETING REPORT FROM THE “MELANOMA BRIDGE. NAPOLI, DECEMBER 3rd-6th 2014”
Ascierto P.A., Atkins M., Bifulco C., Botti G., Cochran A., Davies M., Demaria S., Dummer R., Ferrone S., Formenti S., Gajewski T.F., Garbe C., Hodi F.S., Khleif S., Kiessling R., Lo R., Lorigan P., Mc Arthur G., Masucci G., Melero I., Mihm M., Palmieri G., Parmiani G., Puzanov I., Romero P., Schilling B., Seliger B., Stroncek D., Taube J., Tomei S., Zarour H.M., Testori A., Wang E., Galon J., Ciliberto G., Mozzillo N., Marincola F.M. and Thurin M.
Ascierto et al. J Transl Med (2015) 13:374
MELANOMA BRIDGE 2014 MEETING ABSTRACTS
Journal of Translational Medicine 2015, Volume 13 Suppl 1
FUTURE PERSPECTIVES IN MELANOMA RESEARCH. MEETING REPORT FROM THE “MELANOMA BRIDGE. NAPOLI, DECEMBER 5th-8th 2013”
Ascierto P.A., Grimaldi A.M., Carrizosa Anderson A., Bifulco C., Cochran A., Garbe C., Eggermont A.M., Faries M., Ferrone S., Gershenwald J.E., Gajewski T.F., Halaban R., Hodi F.S., Kefford R., Kirkwood J.M., Larkin J., Lo R.S., Leachman S., Maio M., Marais R., Masucci G., Melero I., Palmieri G., Puzanov I., Ribas A., Saenger Y., Schilling B., Seliger B., Stroncek D., Sullivan R., Testori A., Wang E., Ciliberto G., Mozzillo N., Marincola F.M. and Thurin M.
Ascierto et al. Journal of Translational Medicine 2014, 12:277
MELANOMA BRIDGE 2013: POSTER AND ORAL PRESENTATIONS
Journal of Translational Medicine 2014, Volume 12 Suppl 1
FUTURE PERSPECTIVES IN MELANOMA RESEARCH. MEETING REPORT FROM THE “MELANOMA BRIDGE. NAPOLI, DECEMBER 2ND-4TH 2012”
Ascierto P.A., Grimaldi A.M., Acquavella N., Borgognoni L., Calabrò L., Cascinelli N., Cesano A., Del Vecchio M., Eggermont A.M., Faries M., Ferrone S., Fox B.A., Gajewski T.F., Galon J., Gnjatic S., Gogas H., Kashani-Sabet M., Kaufman H.L., Larkin J., Lo R.S., Mantovani A., Margolin K., Melief C., McArthur G., Palmieri G,, Puzanov I., Ribas A., Seliger B., Sosman J., Suenaert P., Tarhini A.A., Trinchieri G., Vidal-Vanaclocha F., Wang E., Ciliberto G., Mozzillo N., Marincola F.M. and Thurin M.
Ascierto et al. Journal of Translational Medicine 2013, 11:137
CROHN’S DISEASE: AN ECONOMIC ASSESSMENT OF BIOLOGICAL DRUGS IN ITALY
Cicchetti A., Gasbarrini A., Ruggeri M. and the WEF study group.
Poster PGI 29 – Dublino, ISPOR 16th European Congress. 2013.
HEPATOCELLULAR CARCINOMA: AN EPIDEMIOLOGICAL AND MANAGEMENT SURVEY-BASED ANALYSIS IN ITALY
Cicchetti A., Gasbarrini A., Ruggeri M., Sacchini D. and the WEF studymgroup.
Poster PGI 8 – Dublino, ISPOR 16th European Congress. 2013.
WORKSHOP IN PHARMACOECONOMICS: AN ITALIAN EXPERIENCE OF MULTI-STAKEHOLDER HTA CONSENSUS
Cicchetti A., Gasbarrini A., Ruggeri M., Sacchini D., Lanati E.P. and the WEF study group.
Poster PHP 159 – Dublino, ISPOR 16th European Congress. 2013.
HOW THE PRICING STRATEGY OF 2ND GENERATION HCV DIRECT ANTIVIRAL AGENTS CAN AFFECT THE NUMBER OF TREATED PATIENTS IN ITALY AND THE NATIONAL DRUG BUDGE
Lanati E.P., Lidonnici D., Cammà C. and the WEF study group.
Poster PGI 47 – Dublino, ISPOR 16th European Congress. 2013.
COST-EFFECTIVENESS OF SORAFENIB TREATMENT IN FIELD PRACTICE FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA
Camma C., Calibbo G., Petta S., Enea M., Iavarone M., Grieco A., Gasbarrini A., Villa E., Zavaglia C., Bruno R., Colombo M., Craxì A., WEF study group and the SOFIA study group.
Hepatology. 2013 Mar;57(3):1046-54
CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) — EXPLANATION AND ELABORATION: A REPORT OF THE ISPOR HEALTH ECONOMIC EVALUATION PUBLICATION GUIDELINES GOOD REPORTING PRACTICES TASK FORCE ELENA PAOLA LANATI – REVIEWER
Husereau D., Drummond M., Petrou S., Carswell C., MSc, Moher D., Greenberg D., Augustovski F., H. Briggs A., Mauskopf J., Loder E., on behalf of the ISPOR Health Economic Evaluation Publication Guidelines – CHEERS Good Reporting Practices Task Force
VALUE IN HEALTH 16 ( 2013 ) 231 –250
THE ROLE OF BRAF V600 MUTATION IN MELANOMA
Ascierto P.A., Kirkwood J.M., Grob J.J., Simeone E., Grimaldi A.M., Maio M., Palmieri G., Testori A., Marincola F.M. and Mozzillo N.
Journal of Translational Medicine. 2012.
EFFECT OF DISCOUNTING ON ESTIMATION OF BENEFITS DETERMINED BY HEPATITIS C TREATMENT
Messori A., Fadda V., Maratea D., Trippoli S.
World J Gastroenterol. 2012.
COST-EFFECTIVENESS OF BOCEPREVIR OR TELAPREVIR FOR UNTREATED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C.
Camma C., Petta S., Enea M., Bruno R., Bronte F., Capurusi V., Cicchetti A., Colombo GL., Di Marco V., Gasbarrini A., Craxì A. and the WEF Study Group.
American Association for the Study of Liver Diseases. 2012.